资讯

Rheumatology Advisor16 小时
Study Suggests GLP-1RAs May Reduce Dementia Risk
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.